FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suzanne Cholerton

Research Profile

Chemicals & Drugs

Physiology

Concepts & Ideas

Gene Frequency

Genes & Molecular Sequences

Alleles

Geographic Areas

Co-author Network

Publications

TOP 3
I Willits; Lisa Price; Annie Parry; Michael J Tilby; D Ford; Suzanne Cholerton; Andrew D J Pearson; Alan V Boddy
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer.
Neslihan Aygün Kocabaş; Semra Sardaş; Suzanne Cholerton; Ann K Daly; Atilla H Elhan; Ali Esat Karakaya
Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
Neslihan Aygün Kocabaş; Semra Sardaş; Suzanne Cholerton; Ann K Daly; Ali Esat Karakaya
N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suzanne Cholerton (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: I Willits; Lisa Price; Annie Parry; Michael J Tilby; D Ford; Suzanne Cholerton; Andrew D J Pearson; Alan V Boddy
Pharmacokinetics and metabolism of ifosfamide in relation to DNA damage assessed by the COMET assay in children with cancer.
British journal of cancer 2005;92(9):1626-35.
2005: Neslihan Aygün Kocabaş; Semra Sardaş; Suzanne Cholerton; Ann K Daly; Atilla H Elhan; Ali Esat Karakaya
Genetic polymorphism of manganese superoxide dismutase (MnSOD) and breast cancer susceptibility.
Cell biochemistry and function 2005;23(1):73-6.
2004: Neslihan Aygün Kocabaş; Semra Sardaş; Suzanne Cholerton; Ann K Daly; Ali Esat Karakaya
N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
International journal of toxicology 2004;23(1):25-31.
2002: Neslihan Aygün Kocabaş; Semra Sardaş; Suzanne Cholerton; Ann K Daly; Ali Esat Karakaya
Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
Archives of toxicology 2002;76(11):643-9.
2001: N A Kocabaş; Ali Esat Karakaya; Suzanne Cholerton; S Sardaş
Catechol-O-methyltransferase (COMT) genetic polymorphism in a Turkish population.
Archives of toxicology 2001;75(7):407-9.
2001: Ismet Cok; N Aygün Kocabaş; Suzanne Cholerton; Ali Esat Karakaya; S Sardaş
Determination of coumarin metabolism in Turkish population.
Human & experimental toxicology 2001;20(4):179-84.
1999: S Murray Yule; D Walker; M Cole; L McSorley; Suzanne Cholerton; Ann K Daly; Andrew D J Pearson; Alan V Boddy
The effect of fluconazole on cyclophosphamide metabolism in children.
Drug metabolism and disposition: the biological fate of chemicals 1999;27(3):417-21.
1998: Hakam Hadidi; Y Irshaid; C B Vågbø; A Brunsvik; Suzanne Cholerton; K Zahlsen; JR Idle
Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
European journal of clinical pharmacology 1998;54(5):437-41.
1998: Ann K Daly; S C Monkman; J Smart; A Steward; Suzanne Cholerton
Analysis of cytochrome P450 polymorphisms.
Methods in molecular biology (Clifton, N.J.) 1998;107():405-22.
1997: C Boustead; H Taber; JR Idle; Suzanne Cholerton
CYP2D6 genotype and smoking behaviour in cigarette smokers.
Pharmacogenetics 1997;7(5):411-4.
1997: Hakam Hadidi; K Zahlsen; JR Idle; Suzanne Cholerton
A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 1997;35(9):903-7.
1996: Suzanne Cholerton; C Boustead; H Taber; A Arpanahi; JR Idle
CYP2D6 genotypes in cigarette smokers and non-tobacco users.
Pharmacogenetics 1996;6(3):261-3.
1996: S C Monkman; Janice S Ellis; Suzanne Cholerton; J Mark Thomason; Robin A Seymour; JR Idle
Automated gas chromatographic assay for amlodipine in plasma and gingival crevicular fluid.
Journal of chromatography. B, Biomedical applications 1996;678(2):360-4.
1995: Hakam Hadidi; Suzanne Cholerton; S Atkinson; Y M Irshaid; N M Rawashdeh; JR Idle
The N-oxidation of trimethylamine in a Jordanian population.
British journal of clinical pharmacology 1995;39(2):179-81.
1994: Ann K Daly; Suzanne Cholerton; M Armstrong; JR Idle
Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Environmental health perspectives 1994;102 Suppl 9():55-61.
1994: Hakam Hadidi; Suzanne Cholerton; S C Monkman; M Armstrong; Y M Irshaid; N M Rawashdeh; Ann K Daly; JR Idle
Debrisoquine 4-hydroxylation (CYP2D6) polymorphism in Jordanians.
Pharmacogenetics 1994;4(3):159-61.
1994: D Walker; J P Flinois; S C Monkman; C Beloc; Alan V Boddy; Suzanne Cholerton; Ann K Daly; Michael Lind; Andrew D J Pearson; Philippe Beaune
Identification of the major human hepatic cytochrome P450 involved in activation and N-dechloroethylation of ifosfamide.
Biochemical pharmacology 1994;47(7):1157-63.
1994: Suzanne Cholerton; A Arpanahi; N McCracken; C Boustead; H Taber; E Johnstone; Julian B S Leathart; Ann K Daly; JR Idle
Poor metabolisers of nicotine and CYP2D6 polymorphism.
Lancet 1994;343(8888):62-3.
1993: Ann K Daly; Suzanne Cholerton; W Gregory; JR Idle
Metabolic polymorphisms.
Pharmacology & therapeutics 1993;57(2-3):129-60.
1992: JR Idle; M Armstrong; Alan V Boddy; C Boustead; Suzanne Cholerton; J Cooper; Ann K Daly; J Ellis; W Gregory; Hakam Hadidi
The pharmacogenetics of chemical carcinogenesis.
Pharmacogenetics 1992;2(6):246-58.
1992: Suzanne Cholerton; Ann K Daly; JR Idle
The role of individual human cytochromes P450 in drug metabolism and clinical response.
Trends in pharmacological sciences 1992;13(12):434-9.
1992: M Armstrong; Ann K Daly; Suzanne Cholerton; D N Bateman; JR Idle
Mutant debrisoquine hydroxylation genes in Parkinson's disease.
Lancet 1992;339(8800):1017-8.
1992: Suzanne Cholerton; M E Idle; A Vas; F J Gonzalez; JR Idle
Comparison of a novel thin-layer chromatographic-fluorescence detection method with a spectrofluorometric method for the determination of 7-hydroxycoumarin in human urine.
Journal of chromatography 1992;575(2):325-30.
1990: C Edwards; S Monkman; Suzanne Cholerton; M D Rawlins; JR Idle; R E Ferner
Lack of effect of co-trimoxazole on the pharmacokinetics and pharmacodynamics of nifedipine.
British journal of clinical pharmacology 1990;30(6):889-91.
1990: R E Ferner; S Monkman; J Riley; Suzanne Cholerton; JR Idle; D N Bateman
Pharmacokinetics and toxic effects of nifedipine in massive overdose.
Human & experimental toxicology 1990;9(5):309-11.